0001882697-21-000001.txt : 20210915
0001882697-21-000001.hdr.sgml : 20210915
20210915160921
ACCESSION NUMBER: 0001882697-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210915
DATE AS OF CHANGE: 20210915
EFFECTIVENESS DATE: 20210915
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Via Nova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001882697
IRS NUMBER: 862573903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-413505
FILM NUMBER: 211255525
BUSINESS ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: SUITE 1300
CITY: OAKLAND
STATE: CA
ZIP: 94607
BUSINESS PHONE: 510-227-2102
MAIL ADDRESS:
STREET 1: 1111 BROADWAY
STREET 2: SUITE 1300
CITY: OAKLAND
STATE: CA
ZIP: 94607
D
1
primary_doc.xml
X0708
D
LIVE
0001882697
Via Nova Therapeutics, Inc.
1111 BROADWAY
SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
510-227-2102
DELAWARE
None
None
Corporation
true
2020
Donald
Ganem
C/O VIA NOVA THERAPEUTICS, INC.
1111 BROADWAY, SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
Executive Officer
Director
Joseph
Jimenez
C/O VIA NOVA THERAPEUTICS, INC.
1111 BROADWAY, SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
Director
Ilan
Zipkin
C/O VIA NOVA THERAPEUTICS, INC.
1111 BROADWAY, SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
Director
Benjamine
Liu
C/O VIA NOVA THERAPEUTICS, INC.
1111 BROADWAY, SUITE 1300
OAKLAND
CA
CALIFORNIA
94607
Director
Biotechnology
Decline to Disclose
- 06b
false
2021-08-31
false
true
false
0
5000001
5000001
0
false
2
0
0
0
false
Via Nova Therapeutics, Inc.
/s/ Donald Ganem
Donald Ganem
President
2021-09-15